(Q43298984)

18 November 2017

title

Pravastatin and cognitive function in the elderly. Results of the PROSPER study (English)

1 reference

18 November 2017

4

Jelle Jolles

1 reference

18 November 2017

9

Naveed Sattar

1 reference

18 November 2017

1

Stella Trompet

1 reference

18 November 2017

16

Rudi G J Westendorp

1 reference

18 November 2017

15

J Wouter Jukema

1 reference

18 November 2017

11

David J Stott

1 reference

18 November 2017

7

Ian Ford

1 reference

18 November 2017

Peter van Vliet

2

1 reference

18 November 2017

Anton J M de Craen

3

1 reference

18 November 2017

Michael B Murphy

6

1 reference

18 November 2017

Peter W Macfarlane

8

1 reference

18 November 2017

Chris J Packard

10

1 reference

18 November 2017

Jim Shepherd

12

1 reference

18 November 2017

Eduard L E M Bollen

13

1 reference

18 November 2017

Gerard J Blauw

14

1 reference

18 November 2017

Brendan M Buckley

5

1 reference

18 November 2017

publication date

4 August 2009

1 reference

18 November 2017

1 reference

18 November 2017

volume

257

1 reference

18 November 2017

issue

1

1 reference

18 November 2017

page(s)

85-90

1 reference

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry

18 November 2017

cites work

1 reference

12 December 2020

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

1 reference

12 December 2020

Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial

1 reference

12 December 2020

Testing cognitive function in elderly populations: the PROSPER study. PROspective Study of Pravastatin in the Elderly at Risk

1 reference

12 December 2020

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

12 December 2020

Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels

1 reference

12 December 2020

The influence of age on the association between cholesterol and cognitive function

1 reference

12 December 2020

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

12 December 2020

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

1 reference

12 December 2020

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Serum cholesterol and cerebrospinal fluid amyloid beta protein in Alzheimer's disease

1 reference

12 December 2020

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease

1 reference

12 December 2020

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

12 December 2020

10.1007/S00415-009-5271-7

Identifiers

DOI

1 reference

18 November 2017

1 reference